<DOC>
	<DOC>NCT00545129</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and efficacy of tanezumab in combination with opioids in treating pain due to cancer that has spread to bone.</brief_summary>
	<brief_title>A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<criteria>Prostate cancer, breast cancer, renal cell carcinoma or multiple myeloma that has spread to bone, causing moderate to severe bone pain. Requires daily opioid medication Patients who do not have bone pain caused by cancer are not eligible for the study. Patients who started chemotherapy less than 4 weeks ago, or who completed radiotherapy less than 4 weeks ago, are not eligible. Known history or evidence of osteoarthritis. History of significant trauma to a major joint within 1 year prior to Screening. Known history of rheumatoid arthritis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>